GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Roche unveils Nigeria’s Premier Health Journalists Academy
Multinational Swiss pharmaceutical company, Roche Products Limited, Thursday launched Nigeria’s foremost Health Journalists Academy, which is aimed at enriching health reportage and coverage in the country by sharpening the skills
NMA decries aggression against government health workers
says personnel are overstretched because of brain drain The Nigerian Medical Association (NMA) has urged members of the public to stop venting their anger or inflicting injuries on medical practitioners
ECOWAS appoints Buhari as ‘champion of COVID-19 response’
President Muhammadu Buhari has been appointed the ‘Champion of the COVID-19 response’ by the Economic Community of West African States (ECOWAS) Authority of Heads of State and Government. The appointment
0 Comments
No Comments Yet!
You can be first to comment this post!